| Name | Title | Contact Details |
|---|
Global Dairy Trade (GDT) is a company that operates dairy trading platforms and supports the development of efficient dairy derivative trading. They connect global pools of buyers and sellers in dairy through their product suite, which includes GDT Eve...
Farmer John is one of the leading companies in the Manufacturing sector.
Drops Candies is a cannabis-infused candy company that serves recreational dispensaries in Oregon and expanding into additional states across the U.S. Their edibles have gained broad popularity in Oregon for their high-quality cannabis ingredients and ...
The PUR Company Inc., are the makers of the #1 selling aspartame-free gum and mints worldwide. We make simple substitutions in everyday favorites, without compromising taste or quality, to promote a healthier lifestyle. We provide the highest quality products and ensure the best level of service for our consumers, partners, family and friends. With a growing number of health-conscious consumers and dietary restrictions, we are made for everyone to enjoy and share. When we say PUR, we really mean it.
Neptune is a biotechnology company engaged primarily in the development and commercialization of marine-derived omega-3 polyunsaturated fatty acids ("PUFAs"). Neptune has a patented process of extracting oils from Antarctic krill, and principally sells omega-3 PUFAs as bulk oil to Neptune`s distributors who commercialize them under their private label primarily in the U.S., European and Australian nutraceutical markets. Neptune`s products generally come in bulk oil or capsule form and serve as a dietary supplement to consumers. Neptune`s head office is located at 545 Promenade du Centropolis, Suite 100, Laval, Quebec. Neptune respectively holds approximately 49% of the participating and voting rights of Acasti and 96% of the voting rights of NeuroBio. Through these subsidiaries, Neptune is also pursuing opportunities in the medical food and prescription drug markets. Acasti and NeuroBio respectively focus on the research and development of safe and therapeutically effective compounds for highly prevalent atherosclerotic conditions, such as cardiometabolic disorders and cardiovascular diseases, and for neurodegenerative and inflammation related conditions. Acasti`s lead prescription drug candidate is CaPre(R), a purified high omega-3 phospholipid concentrate derived from Neptune krill oil being developed to address the prevention and treatment of cardiometabolic disorders, including hypertriglyceridemia, which is characterized by abnormally high levels of triglycerides.